Latest Financials News

Page 4 of 1946
Infratil lifted FY27 operating EBITDAF guidance after a 28% first-half increase, led by data centres, renewables and One NZ. But the growth came with a NZ$247.8 million loss attributable to shareholders, a NZ$256 million incentive-fee provision and a sharp increase in capital spending.
Victor Sage
Victor Sage
18 Nov 2026
Viatris has completed its US$1.69 billion cash acquisition of Pacira BioSciences, taking full ownership of the non-opioid pain management company. Pacira is expected to contribute US$90 million to US$100 million in revenue over the remainder of 2026.
Victor Sage
Victor Sage
18 Nov 2026
Nike has laid out a five-year recovery plan targeting US$5 billion in incremental revenue by fiscal 2031, but the near-term picture remains difficult. Fiscal 2027 revenue is still expected to fall by a high-single-digit percentage, with restructuring costs weighing on earnings.
Logan Eniac
Logan Eniac
18 Nov 2026
JPMorgan Chase has selected Bregje de Best to succeed Jeremy Barnum as chief financial officer after its first-quarter 2027 results. Barnum will become vice chairman and remain with the bank into early 2028, creating an extended handover at the top of finance.
Victor Sage
Victor Sage
18 Nov 2026
Home Depot is changing its top leadership team just as third-quarter sales and comparable-store growth accelerate. Richard McPhail will become CEO, while Ted Decker returns from medical leave to chair the board and the retailer trims its fiscal 2026 earnings outlook to modest growth.
Logan Eniac
Logan Eniac
17 Nov 2026
Orezone Gold delivered record third-quarter production of 59,674 ounces, with revenue of US$238.5 million and operating cash flow of US$71.1 million. The ASX-listed miner also cleared its Bomboré Phase I debt and completed the Stage 2A hard-rock expansion while maintaining 2026 production guidance.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Vitrafy says it has moved from cryopreservation research into commercial execution, with 19 Guardion devices built, new US partnerships and $38.3 million in cash and term deposits. The next test is converting partner evaluations into recurring revenue after a planned FDA Class II listing in the coming weeks.
Victor Sage
Victor Sage
17 Nov 2026
Sandon Capital Investments is promoting a 7.8% fully franked dividend yield and a 7.2% discount to pre-tax NTA, while acknowledging that QPM Energy’s administration cost its portfolio about 7%. The listed investment company says its long-term record and activist holdings continue to offer value, but recent performance has lagged key benchmarks.
Claire Turing
Claire Turing
17 Nov 2026
HighCom Armor has delivered the first batch of rifle-rated combat helmets to the Pakistan Army under a US$1.6 million procurement program. Further deliveries are expected in FY27, but remain subject to final in-field acceptance.
Victor Sage
Victor Sage
17 Nov 2026
Island Pharmaceuticals is moving Galidesivir into a decisive sequence of Marburg animal studies after the FDA confirmed an Animal Rule pathway for the antiviral. The company also expects to generate prospective human data through an approved Uganda Ebola program, although approval, funding and commercial outcomes remain unresolved.
Victor Sage
Victor Sage
17 Nov 2026
Microba Life Sciences has been suspended from trading after revised terms for its proposed Genetic Signatures merger left it unable to complete the second tranche of its institutional placement. The company says it is assessing alternative funding while its cashflow runway narrows.
Victor Sage
Victor Sage
17 Nov 2026
Black Rock Mining has secured a three-month US$5 million drawdown from Tanzanian lender CRDB to fund early works at its Mahenge graphite project. The cash advances earthworks before the wet season, but full project funding and a Final Investment Decision remain outstanding.
Maxwell Dee
Maxwell Dee
17 Nov 2026

Browse the archive

Full archive